Institutional Ownership Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK). We have compiled data on the 446 institutions that hold shares in the stock, with a total of 129 Million shares, which have been reported (via 13F filing form) to have a value of $8.6 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
19,080,496
shares
|
$1.27 Billion
0.64% of portfolio
|
Q3 2025
Added 8.4%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,672,779
shares
|
$975 Million
0.02% of portfolio
|
Q2 2024
Added 18.19%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
11,856,795
shares
|
$788 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.06%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
7,408,561
shares
|
$492 Million
0.07% of portfolio
|
Q3 2025
Reduced 5.35%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
5,617,334
shares
|
$373 Million
0.01% of portfolio
|
Q3 2025
Reduced 11.85%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
4,300,000
shares
|
$286 Million
7.46% of portfolio
|
Q3 2025
Added 17.81%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
3,061,796
shares
|
$203 Million
0.01% of portfolio
|
Q3 2025
Added 15.73%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
3,040,202
shares
|
$202 Million
0.01% of portfolio
|
Q3 2025
Added 1.53%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
2,782,930
shares
|
$185 Million
0.82% of portfolio
|
Q3 2025
Reduced 0.55%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,721,158
shares
|
$181 Million
2.0% of portfolio
|
Q2 2024
Added 7.77%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,366,848
shares
|
$157 Million
0.01% of portfolio
|
Q3 2025
Added 26.84%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,252,206
shares
|
$150 Million
0.09% of portfolio
|
Q2 2023
Reduced 0.8%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,803,251
shares
|
$120 Million
0.02% of portfolio
|
Q3 2025
Reduced 41.27%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,647,725
shares
|
$109 Million
0.46% of portfolio
|
Q3 2025
Added 676.12%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,634,723
shares
|
$109 Million
0.01% of portfolio
|
Q3 2025
Added 28.32%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
1,542,857
shares
|
$103 Million
0.01% of portfolio
|
Q3 2025
Added 16.41%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,521,186
shares
|
$101 Million
0.01% of portfolio
|
Q3 2025
Added 36.05%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,406,832
shares
|
$93.5 Million
0.01% of portfolio
|
Q3 2025
Added 2.0%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
1,400,000
shares
|
$93 Million
5.84% of portfolio
|
Q3 2025
Added 40.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,386,065
shares
|
$92.1 Million
0.01% of portfolio
|
Q3 2025
Added 6.73%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
1,373,883
shares
|
$91.3 Million
0.01% of portfolio
|
Q3 2025
Added 1.24%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,196,868
shares
|
$79.5 Million
1.01% of portfolio
|
Q3 2025
Reduced 8.8%
|
|
|
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Warszawa, R9 |
Nov 12, 2025 Q3 2025 |
1,192,484
shares
|
$79.2 Million
5.06% of portfolio
|
Q3 2025
Added 10.15%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
1,178,780
shares
|
$78.3 Million
0.01% of portfolio
|
Q3 2025
Added 0.91%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
1,174,448
shares
|
$78 Million
0.04% of portfolio
|
Q3 2025
Reduced 0.87%
|
|